Skip to content
Founder TaxPartners

ERIS and the 30% R&D Intensity Test for Loss-Making Startups

11 November 2026 · 7 min read

Get in touch

ERIS is the R&D route for a loss-making SME that spends heavily on R&D. If at least 30% of your total relevant expenditure goes on R&D, you deduct 186% of your qualifying R&D costs and can swap the loss for cash worth up to 14.5% of it. That's up to about £27 for every £100 of R&D, against £16.20 if the same loss-making company claims under the merged scheme. Enhanced R&D Intensive Support (ERIS) has two gates, and you need to get through both.

What ERIS is and who qualifies

Enhanced R&D intensive support (ERIS) is for a loss-making SME whose relevant R&D expenditure is at least 30% of its total relevant expenditure, connected companies included. It gives an extra 86% deduction on qualifying R&D costs (186% in all) and a payable credit worth up to 14.5% of the surrenderable loss. Without it, a loss-making SME claims the merged scheme's 20% credit instead, which is taxable. That's why a pre-revenue software company can get a bigger R&D repayment than a profitable competitor spending the same on R&D.

ERIS isn't open to profitable companies, and it isn't a general top-up. You need both conditions for the period you're claiming for: a trading loss, and R&D spend of at least 30% of the total. There's one easing on the second test. If you met it in your last 12-month accounting period and made a valid SME or ERIS claim for that period on expenditure from 1 April 2023, you can still claim. And even if you qualify, you can choose the merged scheme, but you can't claim both on the same expenditure.

The two gates: loss-making AND at least 30% R&D-intensive

Miss either gate and you're in the merged scheme, not ERIS. Loss-making has a precise meaning here: HMRC treats an SME as loss-making if it makes a trading loss for tax purposes before the extra 86% deduction goes in. You can't use the extra deduction to create the loss that gets you into ERIS. The 30% intensity test is measured on the same period's figures.

So a company that swings into profit can't use ERIS for that period, however much it spends on R&D. And a loss-making company whose R&D is only 20% of its total expenditure doesn't qualify either, even if the spend is large in pounds.

Borderline on either test? It's worth modelling before the accounting period closes, because when you spend the money can move both the intensity ratio and the loss, and the two interact.

How the 30% intensity ratio is calculated

The ratio is relevant R&D expenditure divided by total relevant expenditure for the accounting period. It has to be at least 30% (0.30), or ERIS isn't available.

The numerator is the spend you could claim R&D relief on for the period, whether or not you actually claim it. That's the same categories that feed the claim itself: staff costs, subcontractor costs, consumables, software licences used in the R&D project, and cloud compute you can attribute to qualifying R&D. It has to be work that seeks an advance in science or technology. Routine development doesn't count.

The denominator is total relevant expenditure. In HMRC's merged scheme and ERIS guidance that's the costs that go into your profit before tax under GAAP, plus pre-trading costs you could get SME relief on and amounts deducted in the tax computation under CTA 2009 s1308. It leaves out amortisation added back under s1308 and payments to a connected company. The part that catches startups is connected companies: their spend (worldwide) for any period that overlaps yours goes into both sides of the ratio. If your company's part of a group, or a founder controls another company, that can pull the ratio down a long way, so work it out before you rely on it.

Because admin and sales costs sit in the denominator, a company whose headcount leans towards commercial roles rather than engineering will see its ratio diluted. A pre-revenue company that's almost all engineers is the clearest pass. With a big sales team or high distribution costs, you'll need to work the numbers through carefully.

Calculator

R&D Relief Estimator 2026/27

Enter your qualifying R&D expenditure and company position. The tool shows your merged-scheme net benefit and, where you qualify, the ERIS payable credit. Speak to a specialist before filing.

£

Total qualifying R&D costs for the period: staff, subcontractors or externally provided workers (EPW), software, consumables.

£

The R&D-qualifying fraction of payroll only. Must be no more than total qualifying expenditure above.

Loss-making companies with 30%+ R&D intensity may qualify for the higher ERIS payable credit.

£

Used for the 30% R&D-intensity test (ERIS). Must be greater than zero.

25% main rate, 19% small profits rate, and 26.5% on each extra £1 of profit inside the marginal relief band. Only affects the net value of the merged-scheme taxable credit for a profit-making company; a loss-making company's credit is netted at 19%.

Your result

Your answer's ready. Press below to see it.

The ERIS benefit: 86% additional deduction and 14.5% payable credit

For a period where you get through both gates, ERIS gives an 86% additional deduction on qualifying R&D expenditure, plus a payable credit worth up to 14.5% of the surrenderable loss. Here's how it works for a loss-making company.

You deduct your qualifying R&D costs as normal in the computation, then claim the extra 86% on top of the same spend. As you're already making a loss, that makes the loss bigger. You can then surrender the loss to HMRC for a payable (cash) credit at 14.5%. The surrenderable loss is the unrelieved trading loss or, if that's less, 186% of the qualifying expenditure (CTA 2009 s1055). The credit isn't taxable.

The 86% is an extra deduction, not a top-up to the cost you've already taken. On £100 of qualifying R&D spend, you deduct the £100 as a cost and then a further £86, so £186 of deductions for £100 of spend. If the loss is at least that big, the credit's 14.5% of £186, about £27.

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

Worked example: a loss-making software startup

Nothing here is a real company. We've kept the numbers round so you can check each step and swap in your own.

Company profile: Pre-revenue SaaS company, 12-month accounting period, no connected companies. Two founders and four engineers. Most of the cost is engineering payroll and cloud compute used to develop qualifying software.

Expenditure category Amount Qualifying R&D?
Engineering staff costs (4 engineers, all on qualifying R&D) £360,000 Yes
Cloud compute costs attributable to R&D £90,000 Yes
Software licences used in R&D £30,000 Yes
Founder salaries (not directly in qualifying R&D) £120,000 No
Office, legal, and admin costs £80,000 No
Marketing and sales £120,000 No
Total qualifying R&D expenditure £480,000
Total expenditure (all costs) £800,000

Step 1: intensity test. £480,000 / £800,000 = 60%. That's well above 30%, so gate one's passed.

Step 2: loss-making test. With no revenue and £800,000 of costs, the company's trading loss before the extra deduction is £800,000. Gate two's passed, so ERIS applies.

Step 3: enhanced deduction. The 86% additional deduction applies to the £480,000 of qualifying R&D expenditure.

  • Additional deduction: £480,000 × 86% = £412,800
  • Total R&D deduction (cost + enhancement): £480,000 + £412,800 = £892,800
  • Total loss for the period: £800,000 (trading costs) + £412,800 (enhancement) = £1,212,800 (your actual figure depends on your full computation)

Step 4: payable credit. The surrenderable loss is the lower of the unrelieved trading loss and 186% of the qualifying expenditure:

  • Unrelieved trading loss: £1,212,800. 186% of £480,000: £892,800. Surrenderable loss: £892,800
  • Payable credit: £892,800 × 14.5% = £129,456

Step 5: PAYE cap. The credit can't be more than £20,000 plus 300% of the company's PAYE and National Insurance liabilities for the period, unless it's exempt, and under ERIS a claim above the cap is invalid. Here the cap only bites if those liabilities are below about £36,500 (£20,000 plus 300% of £36,500 is £129,500), and employer NIC alone on roughly £480,000 of payroll is well past that.

That £129,456 is cash from HMRC, not a credit against future profits. For a pre-revenue startup with no tax to pay, that's the point: the credit turns a tax loss into money in the bank. The same company claiming under the merged scheme would get a £96,000 credit (20% of £480,000), worth £77,760 after notional tax at 19%. Our R&D relief estimator gives both figures on these inputs.

The loss you surrender is gone: it can't also be carried forward against future profits. Check the surrenderable amount for your own company before filing.

ERIS vs the merged scheme: which one you land in

Which route you take turns on whether you get through both ERIS gates in the period, and whether you choose to use it. Here's how they compare.

Merged scheme ERIS
Who qualifies All companies (SME or large) that don't meet the ERIS criteria, or that choose the merged scheme Loss-making SME with relevant R&D ≥ 30% of total relevant expenditure
Headline mechanic 20% above-the-line taxable expenditure credit 86% additional deduction + payable credit of up to 14.5% of the surrenderable loss
Profitable company Credit offsets corporation tax liability Not available to profitable companies
Loss-making company Credit reduced by notional tax at 19%, then paid in cash up to the PAYE cap; any excess carries forward Enhanced loss surrendered for a payable credit; a claim above the PAYE cap is invalid
Typical cash benefit on £100 qualifying spend (loss-maker) £20 credit, £16.20 after notional tax at 19% Up to about £27 payable credit (14.5% of £186), before the PAYE cap

The 19% comes from the way the merged credit is paid out: for a company with no profits at the main rate, HMRC takes off notional tax at the small profits rate before paying (CTA 2009 s1042K(5)). For how the merged scheme works for companies that don't use ERIS, see the merged R&D scheme guide.

Getting the claim right: eligibility, notification, and the AIF

Only qualifying R&D counts toward the intensity numerator and the extra deduction, so run your workstreams through the software R&D eligibility guide before you rely on the ratio. Then the same two procedural steps apply as for any R&D claim. First-time claimants, and companies whose last claim was made more than 3 years before their notification period ends, need a claim notification in no later than 6 months after the period of account ends. Claims made from 1 April 2027 shouldn't need one (announced at Budget 2026, still to pass in the Finance Bill). And the Additional Information Form has to reach HMRC before or on the same day as the CT600, form first, or the claim isn't accepted.

Want to model the benefit before committing to a claim? The R&D relief estimator takes your qualifying spend and total expenditure. It'll tell you whether you pass the intensity test and show the indicative ERIS credit next to the merged-scheme figure.

For founders at pre-seed or early funded stage, timing matters. The notification window opens on the first day of the period of account, so you don't have to wait for the year end. If your company's R&D-heavy and loss-making, talk to us early: the R&D claims service covers the whole process, from the eligibility review to the AIF and the CT600. There's more on how R&D relief fits the wider tax picture at each stage on the pages for pre-seed founders and funded startups.

Frequently asked questions

It's the share of a company's spending that goes on R&D: relevant R&D expenditure divided by total relevant expenditure for the period, with the spend of any connected companies counted too. Under ERIS a loss-making SME needs a ratio of at least 30%. Source: gov.uk guidance on the merged R&D expenditure credit scheme and enhanced R&D intensive support.

Divide relevant R&D expenditure by total relevant expenditure for the accounting period. If qualifying R&D spend is £600,000 and total expenditure is £1,800,000, the ratio's 33.3%, which passes. Relevant R&D expenditure is spend you could claim R&D relief on, whether or not you actually claim it. If you've got connected companies, their spend for any overlapping period goes in as well, so check the group before you rely on the ratio.

Up to 14.5% of the surrenderable loss. ERIS first gives an 86% additional deduction on qualifying R&D spend, so £100 of spend becomes £186 of deductions. The surrenderable loss is the unrelieved trading loss or, if less, 186% of the qualifying expenditure (CTA 2009 s1055). So on £100 of spend the most you'll get is about £27. The credit isn't taxable. Source: gov.uk guidance on the merged R&D expenditure credit scheme and enhanced R&D intensive support.

Yes. If it passes the 30% intensity test it can claim under ERIS and swap the enhanced loss for a payable credit worth up to 14.5% of it. If it doesn't, it claims the 20% merged-scheme credit, and a loss-maker gets that in cash after HMRC takes off notional tax at 19%, so £16.20 per £100 of R&D, subject to the PAYE cap. A profitable company can't use ERIS.

Usually, for a company that qualifies. On £100 of qualifying spend ERIS pays up to about £27 (14.5% of £186), while a loss-making company under the merged scheme nets £16.20 (the £20 credit less notional tax at 19%). But the ERIS figure needs a trading loss at least as big as the enhanced spend, and you can't claim both schemes on the same expenditure. You can still pick the merged scheme if it suits you better.

HMRC calls it total relevant expenditure. It's the costs that go into your profit before tax under GAAP, plus pre-trading costs you could get SME relief on (CTA 2009 s1045) and amounts deducted in the tax computation under s1308. It leaves out amortisation added back under s1308 and payments to a connected company. And it includes the spend of connected companies, worldwide, for periods that overlap yours.

Need specialist startup tax advice?

Speak to an accountant who works with funded and scaling UK startups. R&D relief, SEIS/EIS, EMI, founder salary and dividend planning.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)

Related reading